Filter posts

BIO Patient & Health Advocacy Summit: The Power of Partnerships

This week, the BIO Patient & Health Advocacy Summit powered partnerships in the industry to …

Cutting Through the Food Labeling Confusion

There was a lot of media buzz around a Consumer Reports study released yesterday that …

New PhRMA report: Nearly 800 Cancer Medicines in Development

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) shows that biopharma …

Mito What???

Mitochondrial Disease: The Most Common Disease You’ve Probably Never Heard of… About 20 years ago, …

Tekmira Pharmaceuticals Ebola Drug Gets Nod From FDA

The U.S. Food and Drug Administration has authorized Canada’s Tekmira Pharmaceuticals to provide an experimental drug …

Patients Suffering from Gaucher's Disease Deserve Better

Gaucher Disease is one of the over 6,000 rare diseases that affect patients worldwide, representing …

Pro-GMO Labeling Business Faces Own Labeling Dilemma

 “Dr. Bronner’s should spend more time worrying about their own labels.” The Center for Consumer …

Docs to FDA: Biosimilars should have different names than branded drugs

Yesterday, Fierce Biotech highlighted a letter written by more than 10 medical associations and 20 individual specialists …

The “Other Issues to Worry About” vs. GMO’s

We don’t label foods for pesticides, fertilizers or these other “conventional” food-production technologies. Only genetically …

Forbes: Faster FDA Approvals Have Not Caused More Drug Safety Problems

In 1992, Congress, industry, and the FDA worked together to create the Prescription Drug User Fee …